Dysregulated Muscle Lipid Metabolism in African-Americans
非裔美国人肌肉脂质代谢失调
基本信息
- 批准号:6676419
- 负责人:
- 金额:$ 13.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-30 至 2005-08-31
- 项目状态:已结题
- 来源:
- 关键词:African American acyl coA biopsy carbon dioxide caucasian American clinical research disease /disorder proneness /risk electron microscopy enzyme activity exercise fatty acid metabolism female human subject insulin sensitivity /resistance light microscopy long chain fatty acid menstrual cycle mitochondrial membrane noninsulin dependent diabetes mellitus obesity oxidation racial /ethnic difference striated muscles thin layer chromatography women's health
项目摘要
DESCRIPTION (provided by applicant): The prevalence of obesity and diabetes is greater among African-American (AAW) than Caucasian women (CW) in the United States. Although environmental factors may be influential, obese AAW have been shown to possess inherent metabolic defects that suppress lipid oxidation by skeletal muscle. More startling however, is the emerging evidence that these defects may pre-exist in non-obese AAW, predisposing this racial group toward a more rapid onset of fat gain vs. CW. This is fundamentally important because the resultant increase in intramuscular lipid content is strongly linked with insulin resistance and diabetes. Despite the significance of these findings, the cellular mechanisms to explain this racial/ethnic specific metabolic dysfunction remain undefined. Our primary hypothesis is that pre-obese/diabetic AAW possess skeletal muscle with an inherent impairment in the capacity to oxidize long-chain fatty acids (LCFA), leading to a cytotoxic accumulation of bioactive lipids, and precipitation of insulin resistance and diabetes. However, in lean CW, endurance exercise training (EET) stimulates mitochondrial biogenesis, elevating the muscles capacity to oxidize LCFA. Our secondary hypothesis is that AAW will respond to EET by increasing the capacity of skeletal muscle to oxidize lipids, thus reducing the propensity toward developing obesity and diabetes. The aims of the present investigation are 1) to identify the pre-existing cellular site(s) of dysfunction in skeletal muscle LCFA oxidation in lean AAW and 2) to determine whether AAW are responsive to EET. To accomplish our aims, we will investigate 12 sedentary, lean AAW and CW matched for age, BMI (< 25 kg/m2), and menstrual status. Obese subjects from both races will be assessed for comparisons. Skeletal muscle LCFA oxidative capacity will be measured by trapping labeled 14CO2 derived from oxidation by intact muscle strips and homogenates (rectus abdominus) in order to identify the specific cellular defects in lipid metabolism as being due to 1) pre-mitochondrial events 2) mitochondrial activation of LCFA to acyl-CoA 3) the transport of LCFA across the mitochondrial membrane and/or 4) the post-transport mitochondrial oxidative system. Measures of whole body insulin sensitivity will be made to determine the strength of association between the status of skeletal muscle lipid metabolism and insulin action. A subset of subjects from aim 1 and new recruits will undergo 7 days and 8 weeks of EET (cycling) to determine the impact of chronic muscle activity (vastus lateralis) on mitochondrial biogenesis, oxidation of LCFA, and insulin action in AAW. Our findings will be used for subsequent RO1 applications to achieve our Iong-term objective of understanding the mechanism(s) that underlie the greater morbidity and mortality associated with obesity and diabetes in AAW.
描述(由申请人提供):在美国,非裔美国人(AAW)的肥胖和糖尿病患病率高于白人女性(CW)。虽然环境因素可能是有影响的,肥胖AAW已被证明具有固有的代谢缺陷,抑制骨骼肌的脂质氧化。然而,更令人吃惊的是,新出现的证据表明,这些缺陷可能预先存在于非肥胖的AAW中,使这个种族群体比CW更快地开始脂肪增加。这非常重要,因为肌内脂质含量的增加与胰岛素抵抗和糖尿病密切相关。尽管这些发现的意义,细胞机制来解释这种种族/民族特异性代谢功能障碍仍然不明确。我们的主要假设是,前肥胖/糖尿病AAW具有骨骼肌,其氧化长链脂肪酸(LCFA)的能力存在固有损伤,导致生物活性脂质的细胞毒性积累,以及胰岛素抵抗和糖尿病的沉淀。然而,在瘦CW中,耐力运动训练(EET)刺激线粒体生物合成,提高肌肉氧化LCFA的能力。我们的第二个假设是,AAW将通过增加骨骼肌氧化脂质的能力对EET作出反应,从而降低肥胖和糖尿病的倾向。本研究的目的是:1)确定瘦AAW中骨骼肌LCFA氧化功能障碍的预先存在的细胞部位; 2)确定AAW是否对EET有反应。为了实现我们的目标,我们将调查12名久坐、瘦的AAW和CW,年龄、BMI(< 25 kg/m2)和月经状态相匹配。将对来自两个种族的肥胖受试者进行评估以进行比较。将通过捕获来自完整肌肉条和匀浆氧化的标记14 CO2来测量骨骼肌LCFA氧化能力(腹直肌),以鉴定脂质代谢中的特定细胞缺陷是由于1)线粒体前事件,2)LCFA向酰基-CoA的线粒体活化,3)LCFA跨线粒体膜的转运和/或4)线粒体后活化。运输线粒体氧化系统。将测量全身胰岛素敏感性,以确定骨骼肌脂质代谢状态与胰岛素作用之间的关联强度。来自目标1和新招募的受试者亚组将接受7天和8周的EET(骑自行车),以确定慢性肌肉活动(股外侧肌)对AAW中线粒体生物合成、LCFA氧化和胰岛素作用的影响。我们的研究结果将用于随后的RO 1应用,以实现我们的长期目标,即了解AAW中与肥胖和糖尿病相关的更高发病率和死亡率的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RONALD CORTRIGHT其他文献
RONALD CORTRIGHT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RONALD CORTRIGHT', 18)}}的其他基金
Impaired Acyl-CoA Synthetase-Muscle Lipid Oxidation in African American Women
非裔美国女性酰基辅酶 A 合成酶肌肉脂质氧化受损
- 批准号:
7134293 - 财政年份:2006
- 资助金额:
$ 13.95万 - 项目类别:
Impaired Acyl-CoA Synthetase-Muscle Lipid Oxidation in African American Women
非裔美国女性酰基辅酶 A 合成酶肌肉脂质氧化受损
- 批准号:
7289706 - 财政年份:2006
- 资助金额:
$ 13.95万 - 项目类别:
Impaired Acyl-CoA Synthetase-Muscle Lipid Oxidation in African American Women
非裔美国女性酰基辅酶 A 合成酶肌肉脂质氧化受损
- 批准号:
7664461 - 财政年份:2006
- 资助金额:
$ 13.95万 - 项目类别:
Dysregulated Muscle Lipid Metabolism in African-Americans
非裔美国人肌肉脂质代谢失调
- 批准号:
6801021 - 财政年份:2003
- 资助金额:
$ 13.95万 - 项目类别:
Mitochondria-Peroxisome Fatty Acid Oxidation in Obesity
肥胖中的线粒体过氧化物酶体脂肪酸氧化
- 批准号:
6701956 - 财政年份:2003
- 资助金额:
$ 13.95万 - 项目类别:
LIPIDS AND INSULIN RESISTANCE/SIGNALING IN OBESITY
肥胖中的脂质和胰岛素抵抗/信号传导
- 批准号:
2684051 - 财政年份:1998
- 资助金额:
$ 13.95万 - 项目类别:
LIPIDS AND INSULIN RESISTANCE/SIGNALING IN OBESITY
肥胖中的脂质和胰岛素抵抗/信号传导
- 批准号:
2015809 - 财政年份:1997
- 资助金额:
$ 13.95万 - 项目类别:
相似海外基金
Acyl-CoA合成酵素ACSL3のオートファジーにおける役割の解明
阐明酰基辅酶 A 合成酶 ACSL3 在自噬中的作用
- 批准号:
24KJ2017 - 财政年份:2024
- 资助金额:
$ 13.95万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Ceramides as Novel Mediators of Very Long-Chain Acyl-CoA Dehydrogenase Deficiency-Induced Heart Failure.
神经酰胺作为极长链酰基辅酶A脱氢酶缺乏引起的心力衰竭的新型介体。
- 批准号:
10747561 - 财政年份:2023
- 资助金额:
$ 13.95万 - 项目类别:
Acyl-CoA synthetase-mediated regulation of lipid homeostasis
酰基辅酶A合成酶介导的脂质稳态调节
- 批准号:
10189414 - 财政年份:2021
- 资助金额:
$ 13.95万 - 项目类别:
Regulation of acyl-CoA-related enzymes by enzymatically inactive enzyme homolog
酶无活性酶同系物对酰基辅酶A相关酶的调节
- 批准号:
20K05804 - 财政年份:2020
- 资助金额:
$ 13.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Estimation for severity and treatment efficacy of very-long-chain acyl-CoA dehydrogenase deficiency via fatty acid loading test
通过脂肪酸负荷试验评估极长链酰基辅酶A脱氢酶缺乏症的严重程度和治疗效果
- 批准号:
19K17355 - 财政年份:2019
- 资助金额:
$ 13.95万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Characterization of the sex specific metabolic phenotype in very-long chain acyl-CoA dehydrogenase deficient (VLCAD-/-) mice
极长链酰基辅酶 A 脱氢酶缺陷 (VLCAD-/-) 小鼠性别特异性代谢表型的表征
- 批准号:
410964249 - 财政年份:2018
- 资助金额:
$ 13.95万 - 项目类别:
Research Grants
Transport mechanism of very long chain fatty acyl-CoA into peroxisomes mediated by peroxisomal ABC protein ABCD1
过氧化物酶体ABC蛋白ABCD1介导的极长链脂肪酰辅酶A转运至过氧化物酶体的机制
- 批准号:
18K14900 - 财政年份:2018
- 资助金额:
$ 13.95万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Involvement of acyl-CoA thioester metabolite in drug-induced idiosyncratic liver injury
酰基辅酶A硫酯代谢物参与药物引起的特异质肝损伤
- 批准号:
17K08432 - 财政年份:2017
- 资助金额:
$ 13.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




